Published in PLoS Med on October 16, 2012
Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. J Affect Disord (2014) 1.39
Depression is more than the sum score of its parts: individual DSM symptoms have different risk factors. Psychol Med (2013) 1.09
Depression sum-scores don't add up: why analyzing specific depression symptoms is essential. BMC Med (2015) 1.02
The impact of individual depressive symptoms on impairment of psychosocial functioning. PLoS One (2014) 1.02
Dissecting psychiatric spectrum disorders by generative embedding. Neuroimage Clin (2013) 1.01
Problematic assumptions have slowed down depression research: why symptoms, not syndromes are the way forward. Front Psychol (2015) 0.96
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank. Int J Neuropsychopharmacol (2015) 0.94
A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res (2013) 0.90
TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. Mol Psychiatry (2016) 0.86
Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology (Berl) (2015) 0.86
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response. Transl Psychiatry (2015) 0.85
DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP. Transl Psychiatry (2013) 0.81
Whole-genome association analysis of treatment response in obsessive-compulsive disorder. Mol Psychiatry (2015) 0.81
The paradox of mental health: over-treatment and under-recognition. PLoS Med (2013) 0.80
The differential influence of life stress on individual symptoms of depression. Acta Psychiatr Scand (2015) 0.80
Personalized psychiatry: many questions, fewer answers. J Psychiatry Neurosci (2013) 0.79
Genome-wide association study of response to cognitive-behavioural therapy in children with anxiety disorders. Br J Psychiatry (2016) 0.78
A genome-wide association study of antidepressant response in Koreans. Transl Psychiatry (2015) 0.77
Genetic prediction of antidepressant drug response and nonresponse in Korean patients. PLoS One (2014) 0.77
Exploring the role of drug-metabolising enzymes in antidepressant side effects. Psychopharmacology (Berl) (2015) 0.77
Psychiatric genetics and the future of personalized treatment. Depress Anxiety (2014) 0.76
Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression. Am J Med Genet B Neuropsychiatr Genet (2016) 0.75
Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway. BMC Psychiatry (2016) 0.75
Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans. Sci Rep (2016) 0.75
Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry. EPMA J (2017) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 45.33
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26
Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet (2007) 24.68
Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet (2006) 17.36
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Estimation of significance thresholds for genomewide association scans. Genet Epidemiol (2008) 8.88
Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25
Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet (2009) 5.98
Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet (2005) 4.15
Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can J Psychiatry (2002) 3.71
A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry (2010) 2.77
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry (2010) 2.41
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry (2008) 2.35
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry (2009) 2.15
Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry (2010) 2.06
Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology (2006) 1.66
Don't split your data. Eur J Epidemiol (2010) 1.41
Trajectories of change in depression severity during treatment with antidepressants. Psychol Med (2009) 1.40
Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J (2009) 1.35
Pharmacogenetics-based therapeutic recommendations--ready for clinical practice? Nat Rev Drug Discov (2005) 1.35
Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. JAMA (2006) 1.25
Facilitating clinical implementation of pharmacogenomics. JAMA (2011) 1.16
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry (2009) 1.13
Pharmacogenomics of antidepressant drugs. Pharmacol Ther (2009) 1.01
Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biol Psychiatry (2010) 0.96
Biomarkers predicting treatment outcome in depression: what is clinically significant? Pharmacogenomics (2012) 0.93
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. Pharmacogenomics (2011) 0.86
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol. Trials (2008) 0.86
Novel consortium to address shortfall in innovative medicines for psychiatric disorders. Nat Rev Drug Discov (2009) 0.84
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Global health 2035: a world converging within a generation. Lancet (2013) 16.85
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet (2007) 13.74
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27
A survey of genetic human cortical gene expression. Nat Genet (2007) 12.04
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Wake-up call for British psychiatry. Br J Psychiatry (2008) 10.30
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Grand challenges in global mental health. Nature (2011) 8.40
Schizophrenia. Lancet (2009) 8.14
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet (2009) 6.21
Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry (2010) 6.15
Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet (2012) 5.99
Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet (2010) 5.78
Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ (2008) 5.71
DNA Pooling: a tool for large-scale association studies. Nat Rev Genet (2002) 5.66
Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ (2012) 5.61
City living and urban upbringing affect neural social stress processing in humans. Nature (2011) 5.46
ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn (2004) 5.31
Patterns of cis regulatory variation in diverse human populations. PLoS Genet (2012) 5.28
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet (2008) 4.96
A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A (2010) 4.94
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry (2012) 4.54
Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet (2009) 4.52
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A (2003) 4.44
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology (2002) 4.20
Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ (2009) 4.18
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci (2009) 4.16
Treating depression in primary care in low-income women in Santiago, Chile: a randomised controlled trial. Lancet (2003) 3.99
A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry (2002) 3.95
PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet (2005) 3.95
Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol (2004) 3.93
Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91
Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet (2009) 3.90
Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry (2008) 3.80
Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ (2003) 3.78
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry (2002) 3.72
Economic evaluation of a general practitioner with special interests led dermatology service in primary care. BMJ (2005) 3.68
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol (2010) 3.61
A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. Br J Gen Pract (2003) 3.57
New parents and mental disorders: a population-based register study. JAMA (2006) 3.52
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A (2009) 3.49
Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet (2010) 3.39
A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology (2007) 3.37
Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet (2009) 3.35
Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ (2005) 3.35
Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet (2008) 3.33
Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res (2002) 3.31
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13